zintick

Emergent BioSolutions EBS

Emergent BioSolutions Inc. · NYSE · Pharmaceutical Preparations

$7.09+6.30%close on Oct. 28, 2026 · volume 799K · Yahoo Finance

Price, last 47 sessions

$6.00$7.00Sept. 2026Oct. 2026
Aug. 24, 2026 to Oct. 28, 2026 · high $7.24 · low $5.18 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Oct. 7, 2026Donald W. DeGolyer
director
Sold
10b5-1 plan
17,800$7.09$126,202
Oct. 1, 2026Paul Anthony Williams
SVP, Products Business
Sold
10b5-1 plan
3,000$6.53$19,590

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 10 →
  • 8-KOct. 16, 2026, 7:48 a.m. ETView on SEC.gov

    Departure/appointment of directors or officers · Financial statements and exhibits

  • 4Oct. 7, 2026, 3:45 p.m. ETView on SEC.gov
  • 4Oct. 5, 2026, 9:16 a.m. ETView on SEC.gov
  • 8-KSept. 14, 2026, 4:02 p.m. ETView on SEC.gov

    Regulation FD disclosure · Financial statements and exhibits

  • 8-KSept. 1, 2026, 4:13 p.m. ETView on SEC.gov

    Other events · Financial statements and exhibits

  • SCHEDULE 13GAug. 14, 2026, 2:37 p.m. ETView on SEC.gov
  • 10-QAug. 5, 2026, 5:47 p.m. ETView on SEC.gov
  • 8-KAug. 5, 2026, 4:06 p.m. ETView on SEC.gov

    Results of operations and financial condition · Costs of exit or disposal activities · Departure/appointment of directors or officers · Regulation FD disclosure · Financial statements and exhibits